SEC Form 4 · accession 0001144204-15-019381
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas H. Tulip
Officer — Chief Bus. Officer
Period of report
Mar 26, 2015
Accepted (ET)
Mar 30, 2015 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 26, 2015 | A | 20,000 | $0.00 | A | 78,418 | D | |
| Common Stock | Mar 26, 2015 | F | 7,645 | $1.65 | D | 70,773 | D | |
| Common Stock | holding | — | — | — | 7,193 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to vesting of performance-based restricted stock upon achieving performance criteria.
- F2Shares withheld by the Issuer to satisfy tax withholding obligations upon the vesting of the restricted stock.